Innovation technologique Liliane Bettencourt (2023-2024) - Stéphanie Lacour

Stéphanie Lacour
Collège de France
Innovation technologique Liliane Bettencourt (2023-2024)
Année 2023-2024

Colloque - La neurotechnologie : The OECD's Work on Responsible Innovation in Neurotechnology

Innovating Responsibly: Neurotechnology Standards and Societal Ethics

Colloque coorganisé par Stéphanie Lacour, chaire Innovation technologique Liliane Bettencourt et Mme Karen Rommelfanger.

Intervenant(s)

Stéphanie Lacour, chaire Innovation technologique Liliane Bettencourt

Stéphanie Lacour
Collège de France
Innovation technologique Liliane Bettencourt (2023-2024)
Année 2023-2024

Colloque - La neurotechnologie : The OECD's Work on Responsible Innovation in Neurotechnology

Innovating Responsibly: Neurotechnology Standards and Societal Ethics

Colloque coorganisé par Stéphanie Lacour, chaire Innovation technologique Liliane Bettencourt et Mme Karen Rommelfanger.

Intervenant(s)

Laura Kreiling, Policy Analyst, OCDE

The presentation consists of three parts, the first focuses on the OECD Recommendation on Responsible Innovation in Neurotechnology [OECD/LEGAL/0457] and presents its development and context, as well as implementation efforts. The second part highlights recent OECD work on the governance emerging technologies that the OECD Neurotechnology Recommendation informed, notably the recently published Framework for Anticipatory Governance of Emerging Technologies. The presentation concludes with a live demonstration of the recently released OECD Neurotechnology Toolkit, a central implementation resource of the OECD Neurotechnology Recommendation.

Laura Kreiling is a management scientist with a PhD from University Paris-Saclay, France. She is passionate about the intersection of academia and industry and worked in the private sector as project manager in the automotive industry and in strategic healthcare management before her academic research on managerial practices and context of innovation intermediary organisations in Europe. At OECD, Laura Kreiling is Policy Analyst and works on topics related to the governance of emerging technologies, including the implementation of the OECD Recommendation on Responsible Innovation in Neurotechnology.

Stéphanie Lacour
Collège de France
Innovation technologique Liliane Bettencourt (2023-2024)
Année 2023-2024

Colloque - La neurotechnologie : Ethics: A Global Compass for Responsible Research and Human Rights – Insights from OECD and UNESCO Perspectives

Innovating Responsibly: Neurotechnology Standards and Societal Ethics

Colloque coorganisé par Stéphanie Lacour, chaire Innovation technologique Liliane Bettencourt et Mme Karen Rommelfanger.

Intervenant(s)

Hervé Chneiweiss, Research Director au CNRS, Neuro-Oncologist à l'Hôpital Universitaire Pitié-Salpêtrière, Président du comité d'éthique de l'Inserm

Since 2015, the OECD has convened a panel of experts to develop a framework for responsible research and innovation in the field of neurotechnologies. This effort culminated in Recommendation 457 in 2019. In France, this recommendation has been implemented through the development of a Charter, which is poised to become European-wide. Additionally, an interactive toolkit has been recently introduced. Concurrently, the UNESCO International Bioethics Committee released a report in 2021 on the ethical implications of neurotechnologies. These findings serve as the foundation for ongoing efforts to adopt a recommendation in 2025, which will serve as legislative groundwork for member states. We will compare and contrast the approaches of both organizations, in which we have actively participated.

Hervé Chneiweiss (MD-PhD) is a neurologist and neuroscientist, senior scientist at CNRS, he has been involved in neurogenetic research on diseases such as cerebellar ataxias and then the molecular mechanisms involved in astrocyte phenotype and plasticity, and the development of brain tumors, their epigenetic and metabolic drivers. Technical approaches include proteomics, metabolism, epigenetics, cell cultures, animal models, single cell. He has published over 170 original scientific papers (h=55, i10 112). He is currently director of the Neuroscience Paris Seine-IBPS research center (CNRS/Inserm/Sorbonne University). Hervé Chneiweiss is also involved in bioethics, adviser for life sciences and bioethics to the Minister of Research and Technology (2000-02), member of the Scientific Council of the French Parliamentary Office for Scientific and Techniques assesment (2003-16), member of the French National Ethics Committee (2013-17), member and chairman of the UNESCO International Bioethics Committee (2014-21), member of the WHO committee on Human genome governance (2019-21), expert for OECD on neurotechnology (since 2015), and currently as chairman of the Inserm Ethics Committee, EMBL Ethics Board, EBRAINS EESC and co-chair AHEG UNESCO for recommendation on neurotechnologies. Former editor in chief of Medicine/Sciences (2006-16). He has published several books for the general public (latest: Notre cerveau, L'Iconoclaste, 2019).

Stéphanie Lacour
Collège de France
Innovation technologique Liliane Bettencourt (2023-2024)
Année 2023-2024

Colloque - La neurotechnologie : Navigating Ethical Translation of Neurotech that Benefits All

Innovating Responsibly: Neurotechnology Standards and Societal Ethics

Colloque coorganisé par Stéphanie Lacour, chaire Innovation technologique Liliane Bettencourt et Mme Karen Rommelfanger.

Intervenant(s)

Karen Rommelfanger, Director, Institute of Neuroethics Think and Do Tank & CEO, Ningen Neuroethics Co-Lab

In this talk, Dr Rommelfanger will highlight the promise and ways forward to address some of the more pressing value conflicts that can arise in the development of brain technology. She will provide examples of promising medical applications and delve into the unique issues that arise related to personal identity, agency, and privacy. In addition, she will address challenges related to long-term responsibility for these devices, including who is accountable for their ongoing functionality and how experimental devices are maintained over time. The talk will also explore the increasingly blurred lines between therapeutic and nonmedical applications of brain technology and the implications of this trend. Dr Rommelfanger will provide overview of the global landscape of national and international governance efforts related to protecting citizens and societies. She will conclude by inviting consideration of how a cross-sectoral and diverse community perspective can better assist in designing a future of neurotech that benefits everyone.

Dr Karen S. Rommelfanger is a leading neurotech ethicist and strategist. She founded the Institute of Neuroethics (IoNx), the first think tank focused solely on neuroethics, promoting trusted neuroscience across various sectors. Through her consultancy, Ningen Neuroethics Co-Lab, she works on applied neuroethics and strategy. Dr Rommelfanger is also a professor at Emory University, with expertise in neurology, psychiatry, and behavioral sciences.

Her research has been published in prestigious journals like Nature and Neuron, and she co-edited the Handbook of Neuroethics. As the first neuroethicist editor at Neuron, she has held key roles with the American Journal of Bioethics Neuroscience and the International Neuroethics Society.

In recognition of her contributions, Dr Rommelfanger was appointed to the US NIH BRAIN Initiative Neuroethics Working Group, DARPA's ELSI Neurotechnology Panel, and the National Academies of Sciences, Engineering, and Medicine's group on responsible neuroscience innovation in Southeast Asia. She has also consulted for the OECD and the Council of Europe, advocating for responsible neurotechnology innovation and neurorights. Dr Rommelfanger co-chaired the Global Neuroethics Workgroup of the International Brain Initiative and served on the World Economic Forum's Global Futures Council. She is a recognized commentator on neuroethics, neurotech innovation, and policy in national and international media.

Stéphanie Lacour
Collège de France
Innovation technologique Liliane Bettencourt (2023-2024)
Année 2023-2024

Colloque - La neurotechnologie : Scaling Neurotechnologies: The Interplay of Ethical, Regulatory and Market Dynamics

Innovating Responsibly: Neurotechnology Standards and Societal Ethics

Colloque coorganisé par Stéphanie Lacour, chaire Innovation technologique Liliane Bettencourt et Mme Karen Rommelfanger.

Intervenant(s)

Olivier Oullier, Co-founder, Inclusive Brains & Chairman, Institute for Artificial Intelligence by Biotech Dental

As neurotechnologies transition from research labs to mainstream markets, they encounter a complex array of ethical considerations, regulatory frameworks, and market dynamics. The ethical and regulatory responses to the swift deployment of AI-powered neurotech are continually evolving. In this presentation, Oullier will build on his expertise in academia, policymaking, and business to champion proactive engagement with all stakeholders. This approach aims to ensure that the commercial expansion of neurotechnologies aligns with societal values and ethical principles, enhancing human capabilities while safeguarding fundamental rights. Additionally, he will address the risks posed by unregulated commercial practices as well as by poorly informed individuals involved in ethics and regulatory initiatives who are making non-evidence-based claims that could hinder both research and business progress in AI and neurotechnologies.